(Q24243870)

5

object named as

G Peter Herbison

0 references

author name string

Ghulam Nabi

1

0 references

June D Cody

2

0 references

Gaye Ellis

Cochrane Database of Systematic Reviews

3

0 references

publication date

18 October 2006

0 references

published in

0 references

cites work

Behavioral vs Drug Treatment for Urge Urinary Incontinence in Older Women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Psychological improvements associated with behavioral and drug treatment of urge incontinence in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Improved quality of life in patients with overactive bladder symptoms treated with solifenacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Clinical efficacy and tolerability of extended‐release tolterodine and immediate‐release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo‐controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Tolterodine reduces the number of urge incontinence episodes in patients with an overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Efficacy of antimuscarinic therapy for overactive bladder with varying degrees of incontinence severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Tolterodine: a safe and effective treatment for older patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Response to treatment of detrusor instability in relation to psychoneurotic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Dose-ranging study of tolterodine in patients with detrusor hyperreflexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Effect of oxybutynin chloride on bladder spasm following transurethral surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Oxybutynin chloride for geriatric urinary dysfunction: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Increased warning time with darifenacin: a new concept in the management of urinary urgency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Behavioral and drug therapy for urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Does oxybutynin add to the effectiveness of prompted voiding for urinary incontinence among nursing home residents? A placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Effect of trospium chloride on somnolence and sleepiness in patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Pressure-flow variables in patients treated with tolterodine for detrusor overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

A neurologic basis for the overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Anticholinergic drugs versus other medications for overactive bladder syndrome in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Which anticholinergic drug for overactive bladder symptoms in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Urinary, faecal and sexual dysfunction in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

The patient with an overactive bladder--symptoms and quality-of-life issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Economic considerations and outcome measurement in urge incontinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

The prevalence and bothersomeness of lower urinary tract symptoms in women 40-60 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue--the BSW.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

What are pragmatic trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Bladder training for urinary incontinence in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

Pharmacodynamics of anticholinergic agents measured by ambulatory urodynamic monitoring: A study of methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Terodiline: a dose titrated, multicenter study of the treatment of idiopathic detrusor instability in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

The prevalence of urinary dysfunction in Hong Kong Chinese women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia--a double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Urinary incontinence among community-dwelling people aged 40 years or older in Japan: prevalence, risk factors, knowledge and self-perception

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, double-blind, multicentre clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Emepronium bromide in urinary incontinence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Oxybutynin with bladder retraining for detrusor instability in elderly people: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Urinary incontinence in old age. A controlled clinical trial of emepronium bromide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Emepronium Bromide and Flavoxate Hydrochloride in the Treatment of Urinary Incontinence Associated with Detrusor Instability n Elderly Women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Placebo-the Drug of Choice in Female Motor Urge Incontinence?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Dose titration in clinical trials. An example using emepronium carrageenate in detrusor instability

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Terodiline in the treatment of women with urgency and motor urge incontinence. A clinical and urodynamic double-blind cross-over study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Genitourinary dysfunction in a geriatric outpatient population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Effects of terodiline on urinary incontinence among older non-institutionalized women. Terodiline in the Elderly American Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Combined behavioral and drug therapy for urge incontinence in older women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Efficacy and cardiac safety of propiverine in elderly patients - a double-blind, placebo-controlled clinical study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries. A multicentre placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Immediate-release oxybutynin versus tolterodine in detrusor overactivity: a population analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021

Emepronium carrageenate: clinical effects and urinary excretion in treatment of female urge incontinence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003781.PUB2

7 January 2021